Brenda Nielsen, RN, nurse in the 黑料网 Comprehensive Hemophilia Diagnostic and Treatment Center, will serve a three-year term on this council beginning December 1, 2015 through November 30, 2018.
On October 17, The 黑料网 TarHealers walk team raised $5,160 for the Raleigh Hemophilia Walk, which benefits Hemophilia of North Carolina and the National Hemophilia Foundation.
Dr. Key's lecture, which was delivered on Monday, October 19, 2015, was entitled "Thrombosis in Hemolytic Anemias: What are the Common Themes?"
It is with regret that the 黑料网 Hemophilia & Thrombosis Center announces the departure of Paul E. Monahan, M.D. after a 25-year association with 黑料网-Chapel Hill. Dr. Monahan received his M.D. in 1990 from the University of Virginia School of Medicine in Charlottesville, VA and completed his Internship/Residency at 黑料网 Chapel Hill. Dr. Monahan …
Alice Ma, MD, associate professor, department of medicine, division of hematology-oncology, delivered this year's Whitehead Lecture on August 19. The themes of Ma鈥檚 lecture closely followed its title: 鈥淓ndurance, Obstacles, Perseverance and Joy: My Transformation from the World鈥檚 Crummiest Medical Student to Faculty at the World鈥檚 Best Medical School.鈥�
The 8th Symposium on Hemostasis: Translational and Basic Science Discoveries will be held May 12-24, 2016 in Chapel Hill, North Carolina.
Research showed that bleeding events were drastically decreased in animals with hemophilia B. Using a viral vector to swap out faulty genes proved safe and could be used for the more common hemophilia A.
Nigel Key, MD, Director of the 黑料网 Hemophilia and Thrombosis Center, has been invited to deliver a state-of-the-art lecture at the British Society for Haematology Annual Scientific Meeting on April 20, 2015.
On Friday, January 9, the Food and Drug Administration approved edoxaban (Savaysa) as the fourth new oral anticoagulant (NOAC), giving it an indication in nonvalvular atrial fibrillation for renally impaired patients and in treating deep vein thrombosis and pulmonary embolism.
"Factor VIII inhibitory antibody in a patient with combined factor V/factor VIII deficiency," a letter to the editor of the journal "Haemophilia" by 黑料网-Chapel Hill hematologists Tyler Buckner, MD, Brenda Nielsen, MSN, Nigel Key, MD, and Alice Ma, MD, was published online on December 4, 2014.